Innovative Outcomes (OTC:UBQU) Announces Distribution Agreement With MDM Wound Ventures to Distribute New EZE Debride System to Healthcare Professionals in 4.95 Billion Dollar Market
Innovative Outcomes (OTC:UBQU) Announces Distribution Agreement With MDM Wound Ventures to Distribute New EZE Debride System to Healthcare Professionals in 4.95 Billion Dollar Market
Ubiquitech Software
Ubiquitech 軟件
DENVER, CO, April 05, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to announce that its subsidiary, Innovative Outcomes, Inc., has entered into a distribution agreement with MDM Wound Ventures to distribute its new wound debriding system called EZE Debride to healthcare professionals throughout the US, and beyond.
科羅拉多州丹佛,2024 年 4 月 5 日(GLOBE NEWSWIRE)——通過 NewMediaWir — 充滿活力和創新的軟件開發公司Ubiquitech Software Corp.(場外交易代碼:UBQU)欣然宣佈,其子公司Innovative Outcomputes, Inc.已與MDM Wound Ventures簽訂了分銷協議,向美國及其他地區的醫療保健專業人員分發其名爲EZE Debride的新型傷口清創系統。
Wound Debriding is the process of removing dead tissue in and around wounds and is vitally important to the healing and long-term care of wound care patients. In addition, proper in-home wound Debriding cuts down on doctor visits saving money for patients and the healthcare system and helps facilitate faster healing giving patients greater flexibility in their own wound care progress.
傷口清創是去除傷口內和周圍死組織的過程,對傷口護理患者的癒合和長期護理至關重要。此外,適當的居家傷口清理術可減少就診次數,爲患者和醫療保健系統節省資金,並有助於加快癒合,使患者能夠更靈活地進行自己的傷口護理。
Insurance companies require all wounds to have a debridement performed (removal of non-viable tissue) to qualify for insurance reimbursement of wound care dressings. This makes the relationship with MDM and EZE Debride a natural fit. In fact, Modor Intelligence advises the market size for this device to be 4.95 billion with a Compound Annual Growth Rate (CAGR) of 5.97%.
保險公司要求對所有傷口進行清創手術(切除不可存活的組織),才有資格獲得傷口護理敷料的保險報銷。這使得與 MDM 和 EZE Debride 的關係很自然。實際上,Modor Intelligence建議該設備的市場規模爲49.5億美元,複合年增長率(CAGR)爲5.97%。
CEO of Innovative Outcomes, Kevin Lamb, states: "We are excited to distribute this necessary and innovative tool to our healthcare providers and look forward to continued collaboration with MDM Wound Care, and with our current reach into the podiatrist market we see this improving our non-reimbursement revenue exponentially."
創新成果首席執行官凱文·蘭姆表示:“我們很高興向我們的醫療保健提供者分發這種必要的創新工具,並期待與MDM Wound Care繼續合作,隨着我們目前進入足病醫生市場,我們看到這使我們的非報銷收入呈指數級增長。”
EZE Debride's revolutionary design is a single use, disposable instrument that offers both comfort and precision. Features include; Cutting flutes, a flexible neck, counter-balance head, and easy to grip handle. Making EZE Debride the leader in the market.
EZE Debride 的革命性設計是一款一次性儀器,既舒適又精確。功能包括:切割長笛、靈活的琴頸、平衡頭和易於抓握的手柄。讓 EZE Debride 成爲市場的領導者。
Follow Ubiquitech Software Corp, Inc. to learn more about Innovative Outcomes and stay informed about Company developments and growth:
關注Ubiquitech Software Corp, Inc.,了解有關創新成果的更多信息,並隨時了解公司的發展和增長:
Innovative Outcomes Inc.:
創新成果公司:
Ubiquitech Software Corp.:
Ubiquitech 軟件公司:
Follow UBQU on X (Formerly Twitter) @CorporateUBQU
在 X(原推特)上關注 UBQU @CorporateUBQU
Follow Innovative Outcomes on X (Formerly Twitter) @i_outcomes
在 X(前身爲 Twitter)上關注創新成果 @i_outcomes
About Ubiquitech Software Corp.
關於Ubiquitech軟件公司
Ubiquitech Software Corp utilizes its state-of-the-art global internet marketing, Metaverse marketing, Affiliate marketing, Direct Response (DRTV) Television, Radio, Internet Content, SEO, and traditional marketing to drive traffic to its subsidiary.
Ubiquitech Software Corp 利用其最先進的全球互聯網營銷、元界營銷、聯盟營銷、直接響應 (DRTV) 電視、廣播、互聯網內容、SEO和傳統營銷爲其子公司增加流量。
About Innovative Outcomes Inc.
關於創新成果公司
Innovative Outcomes is one of the fastest growing healthcare logistics companies serving medical providers and their patients across the United States. Patients First is more than a catchy phrase - it's our culture.
Innovative Outcomes是增長最快的醫療物流公司之一,爲美國各地的醫療提供商及其患者提供服務。“患者至上” 不僅僅是一句朗朗上口的短語,這是我們的文化。
Our mission is simple: provide ethics-based, compassion-focused assistance to medical providers and their patients. Our iPak – unit dose packaging system makes wound care simple and intuitive for all patients.
我們的使命很簡單:爲醫療服務提供者及其患者提供基於道德的、以同情心爲中心的援助。我們的 iPak — 單位劑量包裝系統使所有患者的傷口護理變得簡單直觀。
As a leader in healthcare technology and logistics, we take the worry out of healing.
作爲醫療保健技術和物流領域的領導者,我們將康復的煩惱排除在外。
Safe Harbor
安全港
Safe Harbor Provision Cautionary statement for purposes of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995: Information in this news release contains forward-looking statements that involve risks, uncertainties, and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of the Company and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks, uncertainties, and assumptions include the execution and performance of contracts by the Company and its customers, suppliers, and partners. Please also review Ubiquitech Software Corporation, Inc. annual and quarterly financials for a more complete discussion of risk factors. The Company disclaims any obligation to update or revise statements contained in this news release based on new information or otherwise. This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state.
就1995年《私人證券訴訟改革法》的 “安全港” 條款而言,安全港條款警告聲明:本新聞稿中的信息包含涉及風險、不確定性和假設的前瞻性陳述。如果此類風險或不確定性成爲現實,或者此類假設被證明不正確,則公司及其合併子公司的業績可能與此類前瞻性陳述和假設所表達或暗示的業績存在重大差異。除歷史事實陳述以外的所有陳述均可被視爲前瞻性陳述。風險、不確定性和假設包括公司及其客戶、供應商和合作夥伴對合同的執行和履行。另請查看Ubiquitech Software Corporation, Inc.的年度和季度財務狀況,以更全面地討論風險因素。公司不承擔根據新信息或其他信息更新或修改本新聞稿中包含的聲明的任何義務。本通信不應構成賣出要約或徵求購買證券要約,在根據任何此類州的法律對這些證券進行註冊或資格認定之前,任何州也不得出售此類證券。
Contact / Investor Relations
IR@UbiquitechSoftwareCorp.com
聯繫方式/投資者關係
IR@UbiquitechSoftwareCorp.com
Attachment
附件
- Ubiquitech Software
- Ubiquitech 軟件